Clinical Trials Logo

Cancer, Lung clinical trials

View clinical trials related to Cancer, Lung.

Filter by:

NCT ID: NCT04074460 Completed - Cancer, Breast Clinical Trials

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

VAPOR-C
Start date: August 27, 2017
Phase: Phase 4
Study type: Interventional

A multicentre, prospective randomized, active-controlled feasibility trial of volatile-based anaesthesia vs. propofol-based total intravenous anaesthesia to investigate the impact of anaesthesia on long-term (i.e. 5-years) patient cancer outcomes in patients undergoing elective major cancer surgery.

NCT ID: NCT04070586 Completed - Cancer, Lung Clinical Trials

Adaptive CT Acquisition for Personalised Thoracic Imaging

ADAPT
Start date: August 21, 2019
Phase:
Study type: Observational

In this trial, Respiratory Motion Guided (RMG) 4DCBCT will be implemented for the first time on lung cancer patients. RMG-4DCBCT adapts the image acquisition as the patient's breathing changes (i.e. if the patient breathes faster, imaging data is acquired faster). By adapting the acquisition to the dynamic patient, personalised images of a patients lungs are able to be acquired for radiotherapy treatments.

NCT ID: NCT03931356 Completed - Clinical trials for Radiotherapy; Complications

Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.

TEFRARC
Start date: January 14, 2019
Phase:
Study type: Observational

assess the consequences of low doses of radiation delivered by the volumetric radiotherapy, on the respiratory capacity of patients treated for bronchopulmonary carcinoma, by a follow up of functional respiratory exploration.

NCT ID: NCT03910283 Not yet recruiting - Clinical trials for Lymphoma, Large B-Cell, Diffuse

Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Mindsets are lenses or frames of mind that orient individuals to a particular set of expectations and associations. This study aims to leverage specific and empirically supported mindsets (i.e., 'cancer is manageable' and 'the body is capable') to reduce distress and improve physical health and psychological wellbeing in patients with cancer being treated with curative intent. This intervention will take the form of several brief documentary style film segments which feature both cancer survivors and experts in the fields of Oncology, Psychology, and Psychiatry. Although no mindset-targeted interventions have been studied in cancer patients to date, other psychosocial interventions have demonstrated efficacy in treating emotional distress and improving quality of life in this population. However, compared with these standard interventions, mindset interventions need not be lengthy, complex, or costly to yield major effects. Thus, this project aims to lay the groundwork for future scalable and efficient interventions that can meaningfully reduce distress and improve health and wellbeing in this population.

NCT ID: NCT03903276 Completed - Cancer, Lung Clinical Trials

Effects of Transcutaneous Electrical Nerve Stimulation in Post-operative Lung Cancer

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Among all cancers, lung cancer is the most common disease on the planet, accounting for 13% of the cases, and leading the number of deaths from malignant diseases. In Brazil, it is estimated that its incidence between 2018 and 2019 could be 18,704 new cases in men and 12,503,000 new cases in women. These data take into account an estimated risk of 18.16 new cases for 100,000 men and 11.81 for 100,000 women, respectively occupying the second and fourth most frequent cases of the disease according to gender . Surgeries, however aggressive they may be, are one of the most viable alternatives for patients with PC, provided it is performed in the milder or early phase of the disease, since after such period this procedure may have a period degree greater than the other forms of treatment. As a consequence, the injuries that the surgical procedure can cause to patients, pain is one of the most influential in the patient's quality of life. It can lead the individual to a marked state of disability both functional and psychological, thus being determinant for the suffering related to the disease, thus comprising its multifactorial character, involving physical, emotional, socio-cultural and environmental aspects . For the control of pain, physiotherapy appears with features such as transcutaneous nerve electrostimulation, where its use for the suppression of pain has become quite feasible due mainly to the ease of its handling, to be noninvasive and to serve to reduce acute pain and chronic. The use of conventional transcutaneous nerve electrostimulation to support the use of analgesics reduced the intensity of pain in patients of the second day of thoracotomy, but for a longer extension of their effects, it would take a longer time to apply the resource, something around 24 -48 hours.

NCT ID: NCT03829618 Terminated - Pneumonia Clinical Trials

Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

Start date: April 1, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.

NCT ID: NCT03750110 Completed - Heart Diseases Clinical Trials

Yorkshire Enhanced Stop Smoking Study

YESS
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

Lung cancer rates are higher in Yorkshire than the rest of the UK, and this is due to higher rates of smoking. Deaths from lung cancer can be reduced using regular lung scans (screening) and by helping people stop smoking. As well as detecting cancers, scans can also show evidence of damage to lungs (emphysema) and heart arteries (calcification). This study will test whether people can be encouraged to quit smoking by giving them pictures from their own scans showing possible lung and heart damage, along with information about how stopping smoking reduces their risk of cancer and heart attacks.

NCT ID: NCT03678090 Withdrawn - Pleural Effusion Clinical Trials

The Safety and Efficacy of Fibrinolysis in Patients With an Indwelling Pleural Catheter for Multi-loculated Malignant Pleural Effusion.

Start date: December 1, 2018
Phase: Phase 2
Study type: Interventional

The safety and efficacy of fibrinolysis in patients with an indwelling pleural catheter for multi-loculated malignant pleural effusion.

NCT ID: NCT03622528 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Quantitative Lung Cancer Screening

Start date: July 2024
Phase:
Study type: Observational

The purpose of this project is to validate quantitative lung structure assessment using an automated analysis software (VIDA), for application to low dose computed tomography (LDCT) acquired for lung cancer screening. Currently the software runs on standard dose CT data. In addition, it is the plan to incorporate algorithms into the software to address assessment of any identified pulmonary lesions.

NCT ID: NCT03569111 Completed - Cancer, Lung Clinical Trials

Clinical Description of a Bronchoscopic Approach to Ablate Lung Nodules Using the Emprint™ Ablation Catheter

NAVABLATE
Start date: February 27, 2019
Phase:
Study type: Observational

The purpose of this investigation is to characterize the safety and performance of the Emprint™ Ablation Catheter Kit with Thermosphere™ Technology in clinical use. This is a prospective, single-arm, multicenter, non-randomized study. Up to 3 sites in up to 3 countries will enroll up to 30 subjects in total. The study is designed to characterize the safety and performance of the bronchoscopic ablation procedure using the Emprint™ Ablation Catheter Kit with Thermosphere™ Technology.